Current and emerging immunotherapeutic approaches for biliary tract cancers
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2022-09-07 / Hepatobiliary Pancreat Dis Int 2022 Oct;21(5):440-449A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2020-11-17 / Cancers (Basel) 2020 Nov;12(11)Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2020-01-24 / Hum Vaccin Immunother 2020 Oct;16(10):2318-2327Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2019-08-07 / World J Gastroenterol 2019 Aug;25(29):3941-3955Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2019-02-27 / Clin Colorectal Cancer 2019 Jun;18(2):81-90Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2018-03-29 / Cancer Immunol Immunother 2018 Dec;67(12):1897-1910Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2018-02-21 / Hum Vaccin Immunother 2018 Jun;14(6):1423-1431Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2017-10-31 / Curr Probl Cancer 2018;42(1):49-58Patient With Unresectable Cholangiocarcinoma Treated With Radiofrequency Hyperthermia in Combination With Chemotherapy: A Case Report
/in Gallbladder Cancer, Hyperthermia, International Publications /von 2017-07-26 / Integr Cancer Ther 2018 06;17(2):558-561
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de